Conditional Inactivation of TACE by a <i>Sox9</i> Promoter Leads to Osteoporosis and Increased Granulopoiesis via Dysregulation of IL-17 and G-CSF
Keisuke Horiuchi(National Defense Medical College), Yoshiaki Toyama(Keio University), Hideo Morioka, Carl Blobel(Hospital for Special Surgery), Haruhiko Akiyama(Hikone Central Hospital), Kana Miyamoto(Kumamoto University), Hironari Takaishi(Keio University), Yasunori Okada(Railway Technical Research Institute), Takashi Nakamura(Jikei University School of Medicine), Takeshi Miyamoto(Kumamoto Health Science University)
Cited by 60
Related Papers
The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of <i>Sox5</i> and <i>Sox6</i>
|Genes & Development|2002|1.7k
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
|Acta Neuropathologica|2009|1k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694